¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell labelling technique"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
cell labeling technique
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
heterotrophic cell
Á¾¼Ó¿µ¾ç¼¼Æ÷
high-threshold cell
°í¹®Åΰª¼¼Æ÷
horizontal cell
¼öÆò¼¼Æ÷
horny cell
°¢Áú¼¼Æ÷
human diploid cell vaccine
»ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
human T-cell lymphoma/leukemic virus
»ç¶÷T¼¼Æ÷¸²ÇÁÁ¾/¹éÇ÷º´¹ÙÀÌ·¯½º
human T-cell lymphotropic virus
»ç¶÷T¼¼Æ÷¸²ÇÁģȹÙÀÌ·¯½º
Hurthle cell adenoma
ÈÖ¸£Æ²·¹¼¼Æ÷»ùÁ¾
hybrid cell
ÀâÁ¾¼¼Æ÷
islet cell
¼¶¼¼Æ÷
islet cell adenoma
¼¶¼¼Æ÷»ùÁ¾
islet cell carcinoma
¼¶¼¼Æ÷¾ÏÁ¾
immunologically competent cell
¸é¿ª¼¼Æ÷
indeterminate cell
ºÎÁ¤Çü¼¼Æ÷
indifferent cell
¹«°ü¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
lymphoid cell
¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ¸ð¾ç¼¼Æ÷
lymphokine-activated killer cell
¸²Æ÷Ä«ÀÎȰ¼º¼¼Æ÷µ¶¼º¼¼Æ÷
lymphopoietic cell
¸²ÇÁ±¸»ý¼º¼¼Æ÷
marrow cell
°ñ¼ö¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mastoid air cell
²ÀÁö¹úÁý
matrix cell
±âÁú¼¼Æ÷, ÅйÙÅÁÁú¼¼Æ÷
memory cell
¸é¿ª±â¾ï¼¼Æ÷
Merkel cell-neurite complex
Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
mesangial cell
Ç÷°ü»çÀ̼¼Æ÷
mesenchymal cell
Áß°£¿±¼¼Æ÷
mesothelial cell
ÁßÇǼ¼Æ÷
microglial cell
¹Ì¼¼¾Æ±³¼¼Æ÷
mitotic cell
ºÐ¿±â¼¼Æ÷
mitral cell
½Â¸ð¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
high peroxidase cell
°íÆä·Ï½Ã´Ù¾ÆÁ¦¼¼Æ÷
hilus cell tumor
¹®¼¼Æ÷Á¾
hilus cell ³ª
¹®¼¼Æ÷(Ú¦á¬øà).
hodgkins disease,lacunar cell in
¿°ø¼¼Æ÷
hodgkins disease,reed-sternberg cell in
¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
horny cell
°¢Áú¼¼Æ÷
huma immunodeficiency virus,follicular dendritic cell infection by
¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T-cell lymphotrophic virus
Àΰ£ T¼¼Æ÷ ¸²ÇÁ ¿µ¾ç¼º ¹ÙÀÌ·¯½º
human t-cell leukemia virus
ÀÎü T¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hybrid cell
ÇÏÀ̺긮µå¼¼Æ÷
hybridoma, B cell
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
cell cycle
¼¼Æ÷ÁÖ±â(¡ñ²Ñ¢)
cell cycle
¼¼Æ÷ÁÖ±â
cell cycle
¼¼Æ÷ÁÖ±â
cell cycle
¼¼Æ÷ÁÖ±â
cell cycle
¼¼Æ÷ÁÖ±â(¡ñ²Ñ¢).
cell cycle
¼¼Æ÷ÁÖ±â
cell cycle time
¼¼Æ÷ÁÖ±â½Ã°£
cell death
¼¼Æ÷»ç(á¬øàÞÝ)
cell death
¼¼Æ÷»ç(á¬øàÞÝ).
cell death
¼¼Æ÷»ç (¡ÞÝ)
cell deficiency (aganglionic megacolon)
¼¼Æ÷ÀÌÁÖ°áÇÌ (¹«½Å°æÀýÁÖ¸§Ã¢ÀÚ
cell differentiation
¼¼Æ÷ºÐÈ(¡ÝÂûù)
cell differentiation
¼¼Æ÷ºÐÈ(¡ÝÂûù).
cell distribution
¼¼Æ÷ºÐÆ÷
cell division
¼¼Æ÷ºÐ¿(¡ÝÂæñ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½